The FDA has placed a clinical hold on a Duchenne muscular dystrophy drug made by Sarepta Therapeutics Inc.
The FDA has placed a clinical hold on a Duchenne muscular dystrophy drug made by Sarepta Therapeutics Inc.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.